Nolato AB: Business Overview, Financials & Competitive Analysis
Nolato AB scores 7/10 on the AskCyborg Cyborg Score (Strong). Diversified specialty polymer manufacturer with strong positioning in growing medical/pharma sectors; valuation ~$1.68B market cap warrants monitoring for turnaround completion and sustained margin expansion. Nolato demonstrates solid fundamentals with $9.66B revenue (2024), approximately 5,500 employees, and diverse end-market exposure. Recent earnings growth of 51% YoY (2024) reflects operational leverage and.
What is Nolato AB's industry? Nolato AB (nolato.com) operates in Specialty Plastics & Polymer Manufacturing; Medical Device Contract Manufacturing. AskCyborg classifies Nolato AB under Specialty Plastics & Polymer Manufacturing; Medical Device Contract Manufacturing in its company registry.
Nolato AB is a Swedish specialty polymer manufacturer and contract manufacturer serving global medical device, pharmaceutical, consumer electronics, telecom, automotive, and industrial sectors. The company designs, de...
Cyborg Score thesis
Diversified specialty polymer manufacturer with strong positioning in growing medical/pharma sectors; valuation ~$1.68B market...
Read the full analyst-debate transcript →Get the Latest Nolato AB Report
Up-to-date AI-powered research, analyst debate audio & saved-company playlists
Get Current Report FreeNolato AB Overview
Pro stress-test →Nolato AB is a Swedish specialty polymer manufacturer and contract manufacturer serving global medical device, pharmaceutical, consumer electronics, telecom, automotive, and industrial sectors. The company designs, develops, and manufactures complex polymer-based products, subsystems, and components for regulated and high-performance applications across Europe, Asia, and North America.
Strategic Profile
Pro stress-test →Nolato operates through three core segments (Medical, Integrated, and Industrial) providing end-market diversification and exposure to growth sectors including life sciences and medical devices. The company combines deep polymer chemistry expertise with advanced manufacturing capabilities (injection molding, silicone processing, assembly) and positions itself as a design-to-manufacturing partner for sophisticated, regulated applications.
Competitive Landscape
Pro stress-test →Nolato competes with specialty polymer processors and contract manufacturers including Trinseo, DuPont de Nemours (specialized polymers division), and European competitors like Freudenberg-Simrit and Hutchinson (France). Key competitive advantages include established relationships in regulated medical/pharma markets, technical depth in custom polymer formulations, and integrated design-to-manufacturing capabilities. Market consolidation trends favor larger players with diversified end-markets.
Industry Context
Nolato AB operates in Specialty Plastics & Polymer Manufacturing; Medical Device Contract Manufacturing.
Key facts
Founded: 1938 · Headquarters: Torekov, Sweden · Employees: 5,461 · Revenue: $9.66B · Market cap: $1.68B